Article Details

Charles River Laboratories Intl. (NYSE:CRL) Upgraded to Buy at Goldman Sachs Group

Retrieved on: 2020-01-09 21:52:30

Tags for this article:

Click the tags to see associated articles and topics

Charles River Laboratories Intl. (NYSE:CRL) Upgraded to Buy at Goldman Sachs Group. View article details on hiswai:

Excerpt

<div><b>Quantum Capital Management</b> bought a new position in shares of Charles River Laboratories Intl. during the 3rd quarter valued at $197,000.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up